“Too Much Medicine” campaign: BMJ speaks out!

Print Friendly, PDF & Email

BMJ News(NaturalHealth365) On May 24, the British Medical Journal (BMJ) published an article titled, “Flu hype and pharma failures: patients deserve better.” In this poignant editorial, the author questions the Atlanta-based Centers for Disease Control and Prevention (CDC) guidelines for flu vaccine recommendations and lays out the argument that “both the dangers of the disease and the need to be vaccinated are being greatly oversold.”

Targeting excessive vaccinations and drug therapy, the BMJ is posturing itself as a potential “friend” of health activists around the world.

Can you believe they’re saying – “Too much medicine”?

Attacking the front on multiple angles, the BMJ has also recently taken a daring step to speak out against Big Pharma and the medical community through the science and discipline of “overdiagnosis” research. By partnering with Ray Moynihan – senior research fellow at Bond University, Australia – the BMJ is launching their “Too Much Medicine” campaign with the primary focus to “highlight the threat to human health posed by overdiagnosis and the waste of resources on unnecessary care.”

In this unprecedented step toward medical integrity and health care acumen, we can only hope more major key players will step up, in the research world, and follow suit.

Are we moving toward greater sustainability?

According to the BMJ, “There is growing evidence that many people are overdiagnosed and overtreated for a wide range of conditions, such as prostate and thyroid cancers, asthma, and chronic kidney disease.” To address these pressing concerns BMJ, editor-in-chief Fiona Godlee, will be working closely with Moynihan.

In the article, introducing the “Too Much Medicine” campaign to the world, Godlee says, “Like the evidence based medicine and quality and safety movements of previous decades, combatting excess is a contemporary manifestation of a much older desire to avoid doing harm when we try to help or heal…Winding back unnecessary tests and treatments, unhelpful labels and diagnoses won’t only benefit those who directly avoid harm, it can also help us create a more sustainable future.”

The BMJ is right! Will the United States healthcare system wake up?

A glaring depiction of U.S. diagnostic integrity can be seen in the number of people who are receiving Social Security benefits because they are labeled as “disabled.” Take a look, for instance, at the latest Census Bureau estimates. If disability were a state in the U.S., it would rank eighth in population!

1. California 38,041,430
2. Texas 26,059,203
3. New York 19,570,261
4. Florida 19,317,568
5. Illinois 12,875,255
6. Pennsylvania 12,763,536
7. Ohio 11,544,225
8. Disability 10,978,040
9. Georgia 9,919,945

Let the numbers speak for themselves. If the U.S. medical system were working, would there be 11 million people – under strict medical management – left unable to work and sanctioned to live on federal funds? Either these people are overdiagnosed and should not be receiving social security benefits, or they are the victims of a type of drug-pushing medical model that is unable to help people get better.

In either case, it is obvious that something needs to be done to address these issues.

This is just the beginning…what’s next?

Be on the lookout for a breakthrough international scientific conference called, Preventing Overdiagnosis. This meeting will be held in September 2013 in Hanover, New Hampshire and is sponsored by the BMJ. According to the BMJ, “The conference seeks to bring together the research and the researchers, advance the science of the problem and its solutions, and develop ways to better communicate about this modern epidemic.”

Registration is now open at www.preventingoverdiagnosis.net.

As part of the campaign, the BMJ will produce a journal issued in early 2014, featuring the best papers from the conference. In addition, the BMJ and the Consumer Reports journal are planning to launch a series on how the expansion of disease definitions is contributing to overdiagnosis.

These reports will feature common conditions including pulmonary embolism, chronic kidney disease and pre-dementia. Underscoring the need for caution, each article will feature a section exposing the dangers of overdiagnosing patients.

About the author: Eric is a peer-reviewed, published researcher. His work on heart disease and autism has been accepted internationally at various scientific conferences through organizations like the American Public Health Association and Australian-based Baker IDI Heart and Diabetes Institute. Be sure to follow his research – here at: NaturalHealth365.com.


SUBSCRIBE TODAY! Click here to join the NaturalNews Inner Circle – a monthly (online) subscription offering exclusive audio interviews, video events, natural health product discounts, free gifts plus much more!

Search here for more related articles about science news
Search here for more related articles about politics and health

STAY INFORMED! FREE Shows + Live Events

Gain INSTANT Access:

  • » Vaccine World Summit
  • » 7-Day Juice Cleanse
  • » FREE Newsletter

Keep Reading:

  • Mama Z

    I think we will see more and more of this! There are other options besides Big Pharma in many cases!

  • Norman Frodsham

    Great News – The BMJ did themselves no favours by supporting the disgraceful attack on Andy Wakefield, and many people lost respect for them.
    Perhaps this is a turning point in the support for big pharma, processed food company’s, and the diabetic scam’s.
    Maybe we will see some true comments about the cancer industry treatment schedules, and how harmful they really are !

  • Susan

    I see prime examples of this in my daily work. With the advancement of patient centered care, we as healthcare providers will be better equipped to coach and provide coping tools for success rather than label “disabled”. We can do better.

  • Suzy

    Thanks to the BMJ for seeing the light and taking action on this issue. Now all they need to do is publicly apologize to Dr. Andrew Wakefield and retract their retraction of the article he co-authored.
    If the BMJ is sponsoring a conference in New Hampshire they (i.e. Fiona Godlee) should appear as Defendant in TX to answer to Dr. Wakefield’s defamation suit. I applaud their stance on overdiagnosis and treatment, but we should not let them off the hook for allowing Brian Deer to sabotage a valid case study and ruin the career of a compassionate and ethical doctor.